PCHC has received The Guideline Advantage™ Hypertension Control and Diabetes Management Achievement Award for attaining specific quality improvement metrics supported by American Heart Association Hypertension Guidelines and American Diabetes Association Standards of Medical Care in Diabetes.
The Guideline Advantage is a quality improvement program in collaboration with American Cancer Society, American Diabetes Association, and American Heart Association that helps outpatient healthcare organizations provide the most up-to-date, research-based care related to prevention and early detection of cancer, cardiovascular disease, and diabetes. The program promotes the use of evidence-based metrics and quality improvement strategies to help organization improve care and provide patients every advantage for a healthy life.
Penobscot Community Health Care earned the award by meeting specific quality achievement measures for the diagnosis and treatment of patients at a nationally recognized level for a designated period. These measures include evaluation of the patient, proper use of medications, and risk-reduction therapies as appropriate.
“PCHC is dedicated to improving the quality of care for our community. Implementing The Guideline Advantage program helped us to accomplish this goal by tracking and measuring our success in meeting internationally-respected guidelines,” said Theresa Knowles, FNP-C, Vice President of Quality Improvement.
“We are pleased to recognize Penobscot Community Health Care for their commitment to improving patient care,” said James R. Langabeer II, MBA, PHD, EMT, national Chairman of The Guideline Advantage Steering Committee and Professor of Emergency Medicine and Clinical Informatics at the University of Texas Health Science Center at Houston. “Preventive health screenings and chronic condition management have a major impact in the health of our communities across the United States. Programs like The Guideline Advantage, which helps providers stay up to date with the latest guidelines and apply them to their patient populations, are critical in our world of fast-paced innovations in technology and patient care.”
The Guideline Advantage™
The Guideline Advantage™ is a collaboration of the American Cancer Society, American Diabetes Association and American Heart Association to develop and pursue strategies for the prevention and early detection of cancer, cardiovascular disease and diabetes. To learn more, visit www.guidelineadvantage.org.